The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma

BACKGROUND: There is strong concern about the costs associated with adding tumor-treating fields (TTF) therapy to standard first-line treatment for glioblastoma (GBM). Hence, we aimed to determine the cost-effectiveness of TTF therapy for the treatment of newly diagnosed patients with GBM. METHODS:...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Bernard-Arnoux, F., Lamure, M., Ducray, F., Aulagner, G., Honnorat, J., Armoiry, X.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2016
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933490/
https://ncbi.nlm.nih.gov/pubmed/27177573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now102
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller